Hims & Hers Health, Inc. $HIMS Shares Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System lifted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 3.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 55,200 shares of the company’s stock after buying an additional 1,600 shares during the period. Louisiana State Employees Retirement System’s holdings in Hims & Hers Health were worth $2,752,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Kingswood Wealth Advisors LLC acquired a new stake in shares of Hims & Hers Health during the second quarter worth $241,000. KLP Kapitalforvaltning AS lifted its stake in shares of Hims & Hers Health by 2.2% during the second quarter. KLP Kapitalforvaltning AS now owns 38,000 shares of the company’s stock worth $1,894,000 after buying an additional 800 shares during the period. True Vision MN LLC lifted its stake in shares of Hims & Hers Health by 3.6% during the second quarter. True Vision MN LLC now owns 9,376 shares of the company’s stock worth $467,000 after buying an additional 328 shares during the period. Diligent Investors LLC lifted its stake in shares of Hims & Hers Health by 15.1% during the second quarter. Diligent Investors LLC now owns 12,556 shares of the company’s stock worth $626,000 after buying an additional 1,649 shares during the period. Finally, Matauro LLC purchased a new position in shares of Hims & Hers Health during the second quarter worth $446,000. 63.52% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently issued reports on HIMS shares. Truist Financial reduced their target price on shares of Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a report on Monday, August 18th. Wall Street Zen cut shares of Hims & Hers Health from a “buy” rating to a “hold” rating in a report on Monday, July 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Hims & Hers Health in a report on Saturday, September 27th. Needham & Company LLC reissued a “hold” rating on shares of Hims & Hers Health in a report on Tuesday, August 5th. Finally, Citigroup reissued a “sell” rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $38.92.

Hims & Hers Health Stock Down 0.1%

HIMS stock opened at $58.13 on Friday. The stock has a market capitalization of $13.14 billion, a P/E ratio of 72.67, a P/E/G ratio of 3.93 and a beta of 2.25. The firm has a 50-day simple moving average of $51.03 and a 200-day simple moving average of $47.78. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a 52 week low of $17.36 and a 52 week high of $72.98.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, August 4th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $544.83 million for the quarter, compared to analysts’ expectations of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The firm’s revenue for the quarter was up 72.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 EPS. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Hims & Hers Health

In other news, insider Irene Becklund sold 8,410 shares of the business’s stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $50.50, for a total transaction of $424,705.00. Following the completion of the sale, the insider owned 1,418 shares of the company’s stock, valued at $71,609. The trade was a 85.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael Chi sold 2,100 shares of the business’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $56.52, for a total transaction of $118,692.00. Following the sale, the insider directly owned 291,439 shares of the company’s stock, valued at $16,472,132.28. This represents a 0.72% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,622,741 shares of company stock valued at $83,695,469. Corporate insiders own 13.71% of the company’s stock.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.